WHITNEY HARRIS: Open Payments
NPI 1821767260 · CABOT, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$990 in 43 payments from 7 companies in 2025. Trend: 2023 $219 · 2024 $328 · 2025 $990
Food & beverage: $990
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $439 |
| Vanda Pharmaceuticals Inc. | 8 | $293 |
| AstraZeneca Pharmaceuticals LP | 8 | $161 |
| Lilly USA, LLC | 3 | $45 |
| Lundbeck LLC | 1 | $24 |
| Amgen Inc. | 1 | $14 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: VRAYLAR, FANAPT, HETLIOZ, AIRSUPRA, BREZTRI, MOUNJARO, REXULTI, MAVYRET.
Industry payments across AR — which companies pay providers there.
